Galena Biopharma to Present at the 7th Annual Bio-Europe International Partnering Conference LAKE OSWEGO, Ore., March 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark W. Schwartz, Ph.D., Executive Vice President and Chief Executive Officer will present a corporate update at the 7^th Annual Bio-Europe International Partnering Conference. The presentation will take place on Tuesday, March 12, 2013 at 9:15 AM local time at the Centre Convencions Internacional Barcelona in Barcelona, Spain. About Galena Biopharma Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com. The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647 CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 firstname.lastname@example.org or Remy Bernarda IR Sense, LLC +1 (503) 400-6995 email@example.com Galena Biopharma, Inc.
Galena Biopharma to Present at the 7th Annual Bio-Europe International Partnering Conference
Press spacebar to pause and continue. Press esc to stop.